Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer

NCT03207139 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Latent Cancer Prostate

Interventions

DRUG: Ga-68 PSMA ligand

Sponsor

Chang Gung Memorial Hospital